Literature DB >> 7519016

Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines.

Y Yamada1, Y Shidoji, Y Fukutomi, T Ishikawa, T Kaneko, H Nakagama, M Imawari, H Moriwaki, Y Muto.   

Abstract

All-trans-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid (designated "acyclic retinoid") induced upregulation of the albumin gene expression at its transcriptional level, whereas all-trans-retinoic acid (RA) induced downregulation of the expression in both PLC/PRF/5 and HuH7 human hepatoma cell lines. These up- and down regulations of the albumin gene expression coordinated with high and low levels of mRNA for hepatocyte nuclear factor-1 (HNF-1), which is one of the most potent transcription factors for the albumin gene, implying that retinoids may regulate albumin gene expression through HNF-1 expression in opposite ways. The PLC/PRF/5 and HuH7 hepatoma cell lines expressed retinoid X receptor-alpha (RXR alpha) mRNA, whose expression was constitutive. Acyclic retinoid and all-trans-RA both induced upregulation of retinoic acid receptor-beta (RAR beta), and both suppressed cell proliferation-related phenotypic expressions by the alpha-fetoprotein gene and the c-myc oncogene. 9-cis-RA, whose receptor is known to be RXR alpha, also induced upregulation of albumin and HNF-1 expression. These results suggest that acyclic retinoid may act through both RXR alpha and RAR beta, whereas all-trans-RA conveys only RAR beta-mediated functions, at least in these two hepatoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519016     DOI: 10.1002/mc.2940100306

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  13 in total

Review 1.  Retinoid roles in blocking hepatocellular carcinoma.

Authors:  Yohei Shirakami; Hiroyasu Sakai; Masahito Shimizu
Journal:  Hepatobiliary Surg Nutr       Date:  2015-08       Impact factor: 7.293

2.  Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells.

Authors:  Yoshihiro Shidoji; Yuki Tabata
Journal:  J Lipid Res       Date:  2019-01-08       Impact factor: 5.922

3.  Reversible upregulation of tropomyosin-related kinase receptor B by geranylgeranoic acid in human neuroblastoma SH-SY5Y cells.

Authors:  Chiharu Sakane; Yoshihiro Shidoji
Journal:  J Neurooncol       Date:  2011-03-04       Impact factor: 4.130

4.  All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPbeta-LIP.

Authors:  Takahiro Masaki; Tomokazu Matsuura; Kiyoshi Ohkawa; Tatsuo Miyamura; Isao Okazaki; Tetsu Watanabe; Tetsuro Suzuki
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

5.  Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Shun-Yuan Jiang; Jung-Mao Chou; Fur-Jiang Leu; Yu-Yen Hsu; Yu-Lung Shih; Jyh-Cherng Yu; Meei-Shyuan Lee; Rong-Yaun Shyu
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

6.  Increase in plasma concentrations of geranylgeranoic Acid after turmeric tablet intake by healthy volunteers.

Authors:  Maiko Mitake; Hiroko Ogawa; Kazuo Uebaba; Yoshihiro Shidoji
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

7.  Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.

Authors:  Masahito Shimizu; Yohei Shirakami; Kenji Imai; Koji Takai; Hisataka Moriwaki
Journal:  J Carcinog       Date:  2012-08-30

8.  Polished rice as natural sources of cancer-preventing geranylgeranoic acid.

Authors:  Takashi Muraguchi; Kyoko Okamoto; Maiko Mitake; Hiroko Ogawa; Yoshihiro Shidoji
Journal:  J Clin Biochem Nutr       Date:  2011-04-26       Impact factor: 3.114

9.  Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma.

Authors:  Masao Honda; Taro Yamashita; Tatsuya Yamashita; Kuniaki Arai; Yoshio Sakai; Akito Sakai; Mikiko Nakamura; Eishiro Mizukoshi; Shuichi Kaneko
Journal:  BMC Cancer       Date:  2013-04-15       Impact factor: 4.430

10.  Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.

Authors:  Masahito Shimizu; Hisataka Moriwaki
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.